Mesenchymal stem cells correct impaired diabetic wound healing by decreasing ECM proteolysis

被引:45
作者
Xu, Junwang [1 ,2 ]
Zgheib, Carlos [1 ,2 ]
Hodges, Maggie M. [1 ,2 ]
Caskey, Robert C. [3 ]
Hu, Junyi [1 ,2 ]
Liechty, Kenneth W. [1 ,2 ]
机构
[1] Univ Colorado, Sch Med, Univ Colorado Denver, Lab Fetal & Regenerat Biol, Anschutz Med Campus, Aurora, CO USA
[2] Childrens Hosp Colorado, Dept Surg, Aurora, CO USA
[3] Univ Penn, Sch Med, Dept Surg, Philadelphia, PA 19104 USA
关键词
diabetes; wound healing; mesenchymal stem cells; extracellular matrix; proteolysis; STROMAL CELLS; BIOMECHANICAL PROPERTIES; DERMAL FIBROBLASTS; PROGENITOR CELLS; MURINE; ANGIOGENESIS; ULCERS; SKIN; METALLOPROTEINASES; DIFFERENTIATION;
D O I
10.1152/physiolgenomics.00090.2016
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Impaired diabetic wound healing is associated with a dermal extracellular matrix protein profile favoring proteolysis; within the healing diabetic wound, this is represented by an increase in activated matrix metalloproteinase (MMPs). Treatment of diabetic wounds with mesenchymal stem cells (MSCs) has been shown to improve wound healing; however, there has not yet been an assessment of their ability to correct dysregulation of MMPs in diabetic wounds. Furthermore, there has been no prior assessment of the role of microRNA29b (miR-29b), an inhibitory regulatory molecule that targets MMP-9 mRNA. Using in vitro models of fibroblast coculture with MSCs and in vivo murine wound healing models, we tested the hypothesis that MSCs correct dysregulation of MMPs in a microRNA-29b-dependent mechanism. In this study, we first demonstrated that collagen I and III protein content is significantly reduced in diabetic wounds, and treatment with MSCs significantly improves collagen I content in both nondiabetic and diabetic wounds. We then found that MMP-9 gene expression and protein content were significantly upregulated in diabetic wounds, indicating elevated proteolysis. Treatment with MSCs resulted in a decrease in MMP-9 gene expression and protein content level in diabetic wounds 3 and 7 days after wounding. Zymographic analysis indicated that MSC treatment also decreased the amount of activated MMP-9 present in diabetic wounds. Furthermore, miR-29b expression was inversely associated with MMP-9 gene expression; miR-29b expression was decreased in diabetic wounds and diabetic fibroblast. Following treatment of diabetic wounds with MSCs, as well as in diabetic fibroblasts cocultured with MSCs, miR-29b was significantly increased. These findings suggest a potential mechanism through which MSCs enhance diabetic wound healing by improving collagen I content in diabetic wounds through decreasing MMP-9 expression and increasing miR-29b expression.
引用
收藏
页码:541 / 548
页数:8
相关论文
共 37 条
[31]   miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition [J].
Wang, B. ;
Li, W. ;
Liu, H. ;
Yang, L. ;
Liao, Q. ;
Cui, S. ;
Wang, H. ;
Zhao, L. .
CELL DEATH & DISEASE, 2014, 5 :e1335-e1335
[32]   Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis [J].
Wu, Yaojiong ;
Chen, Liwen ;
Scott, Paul G. ;
Tredget, Edward E. .
STEM CELLS, 2007, 25 (10) :2648-2659
[33]   WOUND FLUID FROM CHRONIC LEG ULCERS CONTAINS ELEVATED LEVELS OF METALLOPROTEINASES MMP-2 AND MMP-9 [J].
WYSOCKI, AB ;
STAIANOCOICO, L ;
GRINNELL, F .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 101 (01) :64-68
[34]   Effect of miR-29b-1*and miR-29c knockdown on cell growth of the bladder cancer cell line T24 [J].
Xu, Feng ;
Zhang, Qingling ;
Cheng, Wen ;
Zhang, Zhengyu ;
Wang, Jiandong ;
Ge, Jingping .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (06) :1803-1810
[35]   The role of microRNA-15b in the impaired angiogenesis in diabetic wounds [J].
Xu, Junwang ;
Zgheib, Carlos ;
Hu, Junyi ;
Wu, Wenjie ;
Zhang, Liping ;
Liechty, Kenneth W. .
WOUND REPAIR AND REGENERATION, 2014, 22 (05) :671-677
[36]   The Role of MicroRNA-146a in the Pathogenesis of the Diabetic Wound-Healing Impairment Correction With Mesenchymal Stem Cell Treatment [J].
Xu, Junwang ;
Wu, Wenjie ;
Zhang, Liping ;
Dorset-Martin, Wanda ;
Morris, Michael W. ;
Mitchell, Marc E. ;
Liechty, Kenneth W. .
DIABETES, 2012, 61 (11) :2906-2912
[37]  
Zgheib C, 2016, WOUND REPAIR REGEN, V24, P237, DOI 10.1111/wrr.12412